Form D · Biotechnology
Vitazi.AI, Inc.
Santa Fe, NM · CIK 0001959321
Offering snapshot reported Feb 20, 2026 · SEC filing
- Reported sold
- $500K Offering amount: $3M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 31, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 20, 2026 | Initial | $500,000 | No comparison | 1 | SEC filing |
| Dec 23, 2024 | Amendment | $1,215,000 | $555,000vs Jul 31, 2024 | 8 | SEC filing |
| Jul 31, 2024 | Initial | $660,000 | No comparison | 4 | SEC filing |
| Dec 27, 2023 | Amendment | $1,744,999 | $994,999vs Dec 21, 2022 | 7 | SEC filing |
| Dec 21, 2022 | Initial | $750,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-574187
In addition to Total Offering Amount and Total Amount Sold, $1,963,753 in aggregate outstanding convertible indebtedness of the issuer was converted into equity securities in connection with the initial closing of the offering.
Source: Form D, filed Feb 20, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Brett Blackham | Director |
| Charles Breinholt | Director |
| Kristin Gonzales | Director |
| Davin Isakson | Executive |
| Sydnie Keddington | Director |
| Alan Nolley | Director, Executive, Promoter |
| Jeremy Stueven | Director, Executive, Promoter |
| Timothy Summers | Director, Executive, Promoter |
| Waneta Tuttle | Director |
| Jeffrey Wigdahl | Executive |
| Nathan Wyatt | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
3900 Paseo Del Sol
Santa Fe, NM, 87507
Santa Fe, NM, 87507